ProShares Ultra Health Care (NYSEARCA:RXL – Get Free Report) saw a significant decline in short interest during the month of March. As of March 31st, there was short interest totaling 931 shares, a decline of 13.7% from the March 15th total of 1,079 shares. Based on an average trading volume of 9,353 shares, the short-interest ratio is presently 0.1 days. Approximately 0.1% of the shares of the stock are short sold.
ProShares Ultra Health Care Price Performance
RXL stock opened at $47.02 on Friday. The company has a 50 day moving average price of $49.06 and a 200 day moving average price of $49.70. ProShares Ultra Health Care has a fifty-two week low of $36.23 and a fifty-two week high of $55.58. The stock has a market capitalization of $77.11 million, a PE ratio of 24.86 and a beta of 1.27.
ProShares Ultra Health Care Cuts Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Wednesday, March 25th were given a dividend of $0.1444 per share. The ex-dividend date was Wednesday, March 25th. This represents a $0.58 annualized dividend and a dividend yield of 1.2%.
Hedge Funds Weigh In On ProShares Ultra Health Care
ProShares Ultra Health Care Company Profile
ProShares Ultra Health Care (the Fund) seeks daily investment results that correspond to twice (200%) the daily performance of the Dow Jones U.S. Health Care Index (the Index). The Fund intends to invest at least 80% of its net assets, including any borrowings for investment purposes, under normal circumstances, to equity securities contained in the Index and/or financial instruments that, in combination, have similar economic characteristics. The Fund also intends to invest assets not invested in financial instruments, in debt instruments and/or money market instruments.
Read More
Receive News & Ratings for ProShares Ultra Health Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Health Care and related companies with MarketBeat.com's FREE daily email newsletter.
